Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992;42(6):613-8.
doi: 10.1007/BF00265924.

Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?

Affiliations
Clinical Trial

Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?

W M Blankesteijn et al. Eur J Clin Pharmacol. 1992.

Abstract

The effect of beta-adrenoceptor antagonists (BAAs) differing in lipophilicity and partial agonist activity (PAA), and a full agonist, on the dissociation constant for [125I]-(-)- iodocyanopindolol binding to beta 2-adrenoceptors (KD) has been investigated. Twelve healthy, normotensive male volunteers (mean age 22.3 y) were treated with different BAAs according to a cross-over design. The drugs used were propranolol (highly lipophilic BAA, no PAA), pindolol (moderately lipophilic BAA, strong PAA), dilevalol (highly lipophilic BAA, weak PAA) and salbutamol (full agonist). Before and after a single dose and an 8 day course of one of the drugs, blood pressure and the beta 2-adrenoceptor characteristics of mononuclear leukocytes (MNL) were determined. Between the treatment periods, there was a washout interval of 14 days. All BAAs decreased the blood pressure, but only propranolol lowered heart rate. Treatment with salbutamol decreased the diastolic and increased the systolic blood pressure and heart rate. Three hours after the single dose of any of the BAAs, a more than 2-fold increase in KD was observed, and the increase became larger after 8 days of administration (up to 3.7-fold increase). In contrast, no effect on KD was observed after treatment with salbutamol. BAAs with PAA and salbutamol induced a 30% decrease in beta 2-adrenoceptor density. It is concluded that treatment with BAAs, irrespective their lipophilicity or PAA, induces a decrease in the affinity of MNL beta 2-adrenoceptors for antagonists. This phenomenon may help to explain the contradictory relationship between the kinetics and dynamics of BAAs.

PubMed Disclaimer

Similar articles

References

    1. Eur J Pharmacol. 1989 Nov 28;173(1):85-92 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1989 Apr;339(4):479-82 - PubMed
    1. J Cardiovasc Pharmacol. 1989 Jul;14(1):114-20 - PubMed
    1. J Pharmacol Methods. 1985 Nov;14(3):213-28 - PubMed
    1. Eur J Clin Pharmacol. 1984;26(1):7-12 - PubMed

Publication types

LinkOut - more resources